Back to search results

Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

Abroad (travel likely)RecruitingPHASE2

Conditions

Methamphetamine Abuse · Methamphetamine-dependence · Addiction, Substance · Addiction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Rapid Access Addiction Medicine Clinic, St. Paul's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Sahar Reseach Coordinator) · sahar.shahidi@bccsu.ubc.ca
    Contact: Principal Investigator (Paxton Bach, MD)

  • River Stone Recovery Centre, Fredericton, New Brunswick, Canada

  • Center for Addiction and Mental Health, Toronto, Ontario, Canada

    Contact: Study coordinator (Christine Ibrahim) · christine.ibrahim@camh.ca · 416-535-8501
    Contact: Principal Investigator (Bernard Le Foll, MD)

  • University of Montreal Hospital Research Center, Montreal, Quebec, Canada

    Contact: Study coordinator (Amina Sow, Ph.D) · amina.sow.chum@ssss.gouv.qc.ca · 438-860-2452
    Contact: Study coordinator (Heidar Sharafi, Ph.D) · heidar.sharafi.chum@ssss.gouv.qc.ca · 438 860 2452
    Contact: Principal Investigator (Didier Jutras-Aswad, MD)
Study leads

  • Didier Jutras-Aswad

    Principal Investigator

    University of Montreal Hospital Research Center

View source on ClinicalTrials.gov(opens in a new tab)